IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

RTTNews | 968 วันที่ผ่านมา
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

(RTTNews) - Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.

Beaupre's extensive career includes various clinical development and translational research roles in industry, including most recently at BioSplice Therapeutics as Chief Medical Officer and Head of Research and Development in Oncology.

Beaupre previously served as Senior Vice President, Head of Early Oncology Development and Clinical Research at Pfizer, Inc., where he led cross-disciplinary groups including clinical development, clinical pharmacology, translational oncology and clinical operations related study clinicians.

Beaupre also served at Pharmacyclics (Abbvie) as Vice President, Head of Early Development and Immunotherapy, and at Amgen as Medical Director.

He was previously an Assistant Professor at the H. Lee Moffitt Cancer Center and Research Institute, and also held various earlier appointments at the University of Miami and the M.D. Anderson Cancer Center.

แท็ก : IDYA
read more
IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
RTTNews | 519 วันที่ผ่านมา
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews | 702 วันที่ผ่านมา
Swiss Market Ends On Buoyant Note

Swiss Market Ends On Buoyant Note

Swiss stocks closed on a buoyant note on Wednesday, tracking positive cues from markets across Europe and elsewhere, as optimism about the European Union and the U.S. striking a trade deal rose after U.S. President Donald Trump announced deals with Japan and Philippines.
RTTNews | 2 ชม. 22 นาทีที่ผ่านมา
European Stocks Close On Strong Note On Trade Deal Optimism

European Stocks Close On Strong Note On Trade Deal Optimism

European stocks closed on a strong note on Wednesday as prospects of a trade deal between the U.S. and EU increased after U.S. President Donald Trump announced trade deals with Japan and the Philippines.
RTTNews | 2 ชม. 37 นาทีที่ผ่านมา
Canadian Market Up On Trade Deal Hopes

Canadian Market Up On Trade Deal Hopes

The Canadian market hit a fresh record high Wednesday morning, and amid selective buying, remains in positive territory around noon, thanks to rising optimism about several nations striking trade deals with the U.S. before the August 1 deadline.
RTTNews | 4 ชม. 0 นาทีที่ผ่านมา
U.S. Existing Home Sales Slump To Nine-Month Low In June

U.S. Existing Home Sales Slump To Nine-Month Low In June

A report released by the National Association of Realtors on Wednesday showed existing home sales in the U.S. pulled back by more than expected in the month of June. NAR said existing home sales slumped by 2.7 percent to an annual rate of 3.93 million in June after jumping by 1.0 percent to a revised rate of 4.04 million in May.
RTTNews | 5 ชม. 49 นาทีที่ผ่านมา
Positive Start Seen For Canadian Stocks

Positive Start Seen For Canadian Stocks

Bay Street looks headed for a firm start Wednesday morning, tracking positive global cues amid rising prospects of several nations striking trade deals with the U.S. before the August 1 deadline.
RTTNews | 8 ชม. 22 นาทีที่ผ่านมา
AT&T Q2 Results Beat Street; Now Sees FY25 Earnings Inline Or Below Market; Stock Down

AT&T Q2 Results Beat Street; Now Sees FY25 Earnings Inline Or Below Market; Stock Down

Telecom giant AT&T, Inc. on Wednesday reported higher second-quarter profit and revenues, both above market estimates. Further, the firm maintained its fiscal 2025 adjusted earnings outlook, in line or below market. In the pre-market activity on the NYSE, AT&T shares were losing around 3.7 percent.
RTTNews | 8 ชม. 35 นาทีที่ผ่านมา